Stockscreener 앱 받기
86.95
1.25%
1.07
시간 외 거래:
85.43
-1.52
-1.75%
Edwards Lifesciences Corp 주식(EW)의 최신 뉴스
Edwards Lifesciences clears fresh Medicare hurdle, shares consolidate after 52-week high - AD HOC NEWS
SAPIEN 3 Ultra from Edwards Lifesciences Corp.lower-profile TAVI and refined delivery - AD HOC NEWS
Edwards Lifesciences Corp. stock underperforms Monday when compared to competitors - MarketWatch
Edwards Lifesciences Stocklong-term heart valve strategy in focus - AD HOC NEWS
Why Edwards Lifesciences’ Sapien 3 Ultra Resilia aims for quieter TAVI procedures - AD HOC NEWS
Top Edwards Lifesciences (EW) Competitors 2026 - MarketBeat
Edwards Lifesciences CEO Zovighian sells $45,982 of stock By Investing.com - Investing.com India
Edwards Lifesciences CEO Zovighian sells $45,982 of stock - Investing.com
Edwards Lifesciences Corp (EW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Edwards Lifesciences Corp (EW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Edwards Lifesciences Corp (EW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Edwards Lifesciences (EW) CEO sells 523 shares under Rule 10b5-1 plan - Stock Titan
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch
Edwards Lifesciences Corp (EW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Edwards Lifesciences (EW) Hits 52-Week High on Medicare Coverage Proposal - GuruFocus
Edwards Lifesciences (EW) Sees Gains Following CMS Coverage Prop - GuruFocus
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Edwards Lifesciences (EW) Sees 3% Rise Following CMS Coverage An - GuruFocus
Edwards Lifesciences (EW) Sees Positive Coverage Update Boosting Stock Prospects - GuruFocus
Edwards Lifesciences (EW) Gains Analyst Support Amid Coverage Up - GuruFocus
Edwards Lifesciences (EW) Set to Gain from Medicare Coverage Exp - GuruFocus
Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device - Benzinga
Edwards Lifesciences jumps as CMS posts proposed TAVR coverage update - Quiver Quantitative
Is Edwards Lifesciences Ready For Its Next Growth Phase? - Kalkine Media
Edwards Lifesciences stock hits 52-week high at $89.50 By Investing.com - Investing.com Nigeria
Edwards Lifesciences stock hits 52-week high at $89.50 - Investing.com
Why is Edwards Lifesciences stock climbing today? - Investing.com
Edwards Lifesciences stock jumps on TAVR coverage proposal - Investing.com
Leerink reiterates Edwards Lifesciences stock rating on TAVR policy - Investing.com
Leerink reiterates Edwards Lifesciences stock rating on TAVR policy By Investing.com - Investing.com UK
Edwards Lifesciences Corp. stock rises Monday, still underperforms market - MarketWatch
Edwards Lifesciences Stock (US28176E1082): Valuation Metrics Under the Microscope - AD HOC NEWS
Is Edwards Lifesciences stock underperforming the Nasdaq? - MSN
Sector Gamma AS Acquires 23,422 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Parnassus Investments LLC Acquires 111,843 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Stock Watched As Procedure Recovery Matters - Kalkine Media
Deutsche Bank AG Has $475.59 Million Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
CIBC Asset Management Inc Grows Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch
Edwards Lifesciences (NYSE:EW) Hits New 1-Year HighTime to Buy? - MarketBeat
Edwards Tricuspid Valve Gets FDA OK - Orange County Business Journal
Possible Bearish Signals With Edwards Lifesciences Insiders Disposing Stock - Yahoo Finance
Edwards Lifesciences Corp. Hits New 52-Week High at $89.14 - MarketsMojo
Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Edwards Holds Annual Patient Experience Day - Orange County Business Journal
Is Edwards Lifesciences Stock Underperforming the Nasdaq? - Barchart.com
TD Cowen Maintains Edwards Lifesciences(EW.US) With Buy Rating, Raises Target Price to $104 - Moomoo
Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Bank of New York Mellon Corp Sells 1,517,638 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
TD Cowen raises Edwards Lifesciences stock price target on TAVR market share gains - Investing.com
Nomura Asset Management Co. Ltd. Has $36.83 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Edwards Lifesciences (EW) CFO Theodora Mistras files initial Form 3 report - Stock Titan
Intech Investment Management LLC Has $5.91 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
2.86%
0.22%
자본화:
|
볼륨(24시간):